Barington Companies Management acquired 13,000 shares of Chemed for $5.56 million on February 12, 2026. This new position represents 3.65% of the company’s U.S. equity assets. Chemed’s top five holdings include M, MATW, VSCO, BILL, and GIL. The stock price of Chemed was $463.95 on the same day, down 15.18% year-over-year.

Chemed operates in hospice and plumbing services, generating revenue from healthcare and maintenance solutions. The company has a strong presence in healthcare and home services markets, maintaining stable revenue streams. Despite a recent decline in EPS, Chemed continues to grow revenue in both segments, with no current debt and full-year guidance of $22.00 to $22.30 per share.

Consider investing in Chemed with caution, as it was not listed among the 10 best stocks by The Motley Fool Stock Advisor team. The team’s top 10 picks have historically outperformed the market, with an average return of 884%. Investors should focus on Chemed’s cash generation, balance sheet strength, and long-term growth potential in hospice care and plumbing services.

Read more at Yahoo Finance: Chemed Stock Down 15% in a Year as One Fund Builds a $5.56 Million Stake